This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Powderject Research Limited, Oxford Biosciences Limited. Active years: 1997-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxfordshire, GB (1999 - 2007)
- Abingdon, GB (1997 - 2011)
Company Filing History:
Years Active: 1997-2011
Title: John Christopher Greenford: Innovator in Needleless Syringe Technology
Introduction
John Christopher Greenford is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medical technology, particularly in the development of needleless syringe systems. With a total of 11 patents to his name, Greenford's work has the potential to revolutionize how therapeutic agents are delivered.
Latest Patents
Among his latest innovations is a needleless syringe that utilizes supersonic gas flow for particle delivery. This innovative device features a membrane that is ruptured by gas pressure, generating a supersonic gas flow that allows for the injection of particles containing therapeutic agents. This technology aims to enhance patient comfort and improve the efficiency of drug delivery.
Career Highlights
Throughout his career, Greenford has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Powderject Research Limited and Oxford Biosciences Limited. His experience in these organizations has contributed to his expertise in developing advanced medical devices.
Collaborations
Greenford has collaborated with several professionals in his field, including Brian John Bellhouse and David Francis Sarphie. These partnerships have likely enriched his work and led to further advancements in his inventions.
Conclusion
John Christopher Greenford's innovative contributions to needleless syringe technology exemplify his commitment to improving medical practices. His patents and collaborations reflect a dedication to enhancing patient care through advanced delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile